|Articles|April 1, 2019
- Applied Clinical Trials-04-01-2019
- Volume 28
- Issue 4
Applied Clinical Trials, April 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials April 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Global Standardization of Clinical Research Dataalmost 7 years ago
FDA Seeks to Broaden Clinical Trial Eligibility Criteriaalmost 7 years ago
The Framework for FDA’s Real-World Evidence Programalmost 7 years ago
Challenges in Conveying Translational Research Messagealmost 7 years ago
Emerging Biopharma Deserve TLC from CROsalmost 7 years ago
Non-Data Scientists: The Evolving Role of Clinical Data Managementalmost 7 years ago
Optimizing Study Design in Real-World Evidence Generationalmost 7 years ago
Regenerative Medicine Companies Successfully Advance Stem Cell TherapiesNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Clarifying Ownership of IRT Data in Clinical Trials: Distinguishing Investigator-Controlled Data from Sponsor Operational Data
2
Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial
3
Building More Representative Cancer Trial Populations
4
ACT Brief: Reframing Site Initiation Readiness, Operational Execution as Competitive Advantage, and a Historic Motion Sickness Approval
5